BCYC
Price
$22.73
Change
+$0.21 (+0.93%)
Updated
Apr 26, 6:59 PM EST
5 days until earnings call
LYRA
Price
$4.72
Change
-$0.45 (-8.70%)
Updated
Apr 26, 6:59 PM EST
10 days until earnings call
Ad is loading...

Compare predictions BCYC vs LYRA

Header iconBCYC vs LYRA Comparison
Open Charts BCYC vs LYRABanner chart's image
Bicycle Therapeutics
Price$22.73
Change+$0.21 (+0.93%)
Volume$64.01K
CapitalizationN/A
Lyra Therapeutics
Price$4.72
Change-$0.45 (-8.70%)
Volume$90.44K
CapitalizationN/A
View a ticker or compare two or three
BCYC vs LYRA Comparison Chart

Loading...

BCYCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
LYRADaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BCYC vs. LYRA commentary
Apr 27, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and LYRA is a StrongBuy.

COMPARISON
Comparison
Apr 27, 2024
Stock price -- (BCYC: $22.73 vs. LYRA: $4.72)
Brand notoriety: BCYC and LYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 37% vs. LYRA: 41%
Market capitalization -- BCYC: $863M vs. LYRA: $281.99M
BCYC [@Biotechnology] is valued at $863M. LYRA’s [@Biotechnology] market capitalization is $281.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $556.22B to $0. The average market capitalization across the [@Biotechnology] industry is $2.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 0 FA rating(s) are green whileLYRA’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 0 green, 5 red.
  • LYRA’s FA Score: 0 green, 5 red.
According to our system of comparison, BCYC is a better buy in the long-term than LYRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 5 TA indicator(s) are bullish while LYRA’s TA Score has 5 bullish TA indicator(s).

  • BCYC’s TA Score: 5 bullish, 4 bearish.
  • LYRA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, BCYC is a better buy in the short-term than LYRA.

Price Growth

BCYC (@Biotechnology) experienced а -3.07% price change this week, while LYRA (@Biotechnology) price change was -9.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.69%. For the same industry, the average monthly price growth was -8.16%, and the average quarterly price growth was +1262.42%.

Reported Earning Dates

BCYC is expected to report earnings on Aug 01, 2024.

LYRA is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (+1.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BCYC with price predictions.
OPEN
A.I.dvisor published
a Summary for LYRA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BCYC($863M) has a higher market cap than LYRA($282M). BCYC YTD gains are higher at: 25.719 vs. LYRA (-9.924).
BCYCLYRABCYC / LYRA
Capitalization863M282M306%
EBITDAN/AN/A-
Gain YTD25.719-9.924-259%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
BCYCLYRA
RSI
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend about 1 month ago
87%
Bullish Trend 11 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
66%
View a ticker or compare two or three
Ad is loading...
BCYCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
LYRADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSAGX49.611.20
+2.48%
Touchstone Large Company Growth A
AFOCX24.580.19
+0.78%
Archer Focus
ESPAX41.140.11
+0.27%
Allspring Special Small Cap Value A
BAUAX29.500.04
+0.14%
Brown Advisory Small-Cap Fdmtl Val Adv
FGIWX10.78-0.05
-0.46%
Nuveen Global Infrastructure R6

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with PHIO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
+0.93%
PHIO - BCYC
41%
Loosely correlated
-3.40%
MLTX - BCYC
39%
Loosely correlated
+0.57%
ORMP - BCYC
35%
Loosely correlated
+6.96%
SAGE - BCYC
34%
Loosely correlated
+0.81%
AXON - BCYC
34%
Loosely correlated
+0.65%
More